The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Less toxic chemotherapy on the uptake of all lines of chemotherapy in advanced non-small cell lung cancer: A 10-year retrospective population-based review.
Cheryl Ho
Honoraria - Lilly
Research Funding - Lilly; Roche
Katherine Ramsden
No relevant relationships to disclose
Nevin Murray
No relevant relationships to disclose
Sophie Sun
No relevant relationships to disclose
Barbara L. Melosky
Honoraria - Lilly; Roche
Janessa J. Laskin
Honoraria - Lilly; Roche
Research Funding - Lilly; Roche